Despite radical resection, survival rates remain low with high rates of local failure.
As 168 received non-radical treatment, survival analyses are based on 1075 patients, with a median follow-up for living patients of 5.2 years.
Although there is randomized evidence that radical prostatectomy improves survival, there are few data on how benefit varies by baseline risk.
The aim of this study is to evaluate the impact of radical surgery on survival in children over 1 year of age.
This is due in part to late stage at presentation, but even those who are considered fit for radical treatment have low survival rates, approximately 20% 5 year survival after radical surgery and just 6% after radical radiotherapy.
Does a more radical lymphadenectomy confer a survival advantage, or is the improved survival an effect of stage migration?
Accurate prediction of survival after radical prostatectomy (RP) is important for making decisions regarding multimodal therapies.
Concerns remain whether robot-assisted radical cystectomy (RARC) compromises survival because of inadequate oncologic resection or alteration of recurrence patterns.
Castro, E. et al. Effect of BRCA mutations on metastatic relapse and cause-specific survival after radical treatment for localised prostate cancer.
The role of adjuvant radiotherapy (ART) after radical prostatectomy (RP) on survival of patients with prostate cancer (PCa) is still controversial.
